This issue ranges in subject matter from the mind-body level to the molecular, certainly typical of integrative oncology as a whole. We begin with a commentary on the phytochemical quercetin by Salvatore Chirombolo. Like so many other phytochemicals, it is impressively multitargeted, apparently with a special role in the induction of apoptosis.
Editorial
This issue ranges in subject matter from the mind-body level to the molecular, certainly typical of integrative oncology as a whole. We begin with a commentary on the phytochemical quercetin by Salvatore Chirombolo. Like so many other phytochemicals, it is impressively multitargeted, apparently with a special role in the induction of apoptosis.
Our first 2 research articles are studies of yoga for cancer patients. Suzanne Slocum-Giri and colleagues examined the feasibility of a large-scale research program in yoga with cancer patients through qualitative study, identifying both interest in and barriers to such study. Nicole Culos-Reed and colleagues also report a feasibility study, this one based on a pilot trial in prostate cancer patients. This trial had an interest feature in that patients were invited to include a support person in the class. Both studies point the way toward further research on yoga as a viable intervention.
Continuing on the theme of feasibility studies, Leanna Standish and colleagues present preliminary feasibility data for a prospective cohort study with a matched control population. This study, now in progress, aims to examine the impact of integrative oncology on the relapse rate and quality of life of cancer patients. Existing integrative oncology clinics will be the main study sites.
Shi Quan Da Bu Tang is a mixture of tonic or adaptogenic herbs often used in traditional Chinese medicine for treatment of cancer. An observational study by Chen-Jei Tai and colleagues examines the effect of this remedy on hematotoxicity in breast cancer patients receiving chemotherapy, with promising results.
We often assume synergism between multiple natural compounds in targeting cancer: it is not, however, so frequently demonstrated in studies. Daniel Sliva and colleagues do demonstrate this with multiple natural compounds in metastatic cancer cells. Likewise, Ching-Hua Su and colleagues demonstrate synergism between a conventional antifungal compound and a fungal extract from traditional Chinese medicine in promoting apoptosis in cancer cells. Zhi-Yun Cao and colleagues show that effects of low-dose 5-fluorouracil can be increased by combining it with a Chinese herbal combination from the Fu Zheng tradition, used for increasing vital energy and resistance.
In the last of our articles, the ability of Lactobacillus to reduce gastric cancer is explored by Ik Soon Jang and colleagues. While we usually think of Lactobacillus as an aid to digestion, these authors demonstrate its promotion of apoptosis through inhibition of NF-kappaB and mTOR.
Finally, we would like to publicly thank all of our colleagues who worked with us on reviewing articles for ICT
